» Articles » PMID: 32938411

Households Experiencing Catastrophic Costs Due to Tuberculosis in Uganda: Magnitude and Cost Drivers

Abstract

Background: Tuberculosis (TB) patients in Uganda incur large costs related to the illness, and while seeking and receiving health care. Such costs create access and adherence barriers which affect health outcomes and increase transmission of disease. The study ascertained the proportion of Ugandan TB affected households incurring catastrophic costs and the main cost drivers.

Methods: A cross-sectional survey with retrospective data collection and projections was conducted in 2017. A total of 1178 drug resistant (DR) TB (44) and drug sensitive (DS) TB patients (1134), 2 weeks into intensive or continuation phase of treatment were consecutively enrolled across 67 randomly selected TB treatment facilities.

Results: Of the 1178 respondents, 62.7% were male, 44.7% were aged 15-34 years and 55.5% were HIV positive. For each TB episode, patients on average incurred costs of USD 396 for a DS-TB episode and USD 3722 for a Multi drug resistant tuberculosis (MDR TB) episode. Up to 48.5% of households borrowed, used savings or sold assets to defray these costs. More than half (53.1%) of TB affected households experienced TB-related costs above 20% of their annual household expenditure, with the main cost drivers being non-medical expenditure such as travel, nutritional supplements and food.

Conclusion: Despite free health care in public health facilities, over half of Ugandan TB affected households experience catastrophic costs. Roll out of social protection interventions like TB assistance programs, insurance schemes, and enforcement of legislation related to social protection through multi-sectoral action plans with central NTP involvement would palliate these costs.

Citing Articles

Incidence and determinants of households' catastrophic payments for TB care: evidence from a multi-country trial (EXIT-TB project) implemented in East Africa.

Ngadaya F, Philbert D, Wilfred A, Mshiu J, Binyaruka P, Mnyambwa N BMJ Public Health. 2025; 3(1):e001543.

PMID: 40017933 PMC: 11843488. DOI: 10.1136/bmjph-2024-001543.


Impact of diagnosis-related group payment on medical expenditure and treatment efficiency on people with drug-resistant tuberculosis: a quasi-experimental study design.

Xiong Y, Yao Y, Li Y, Chen S, Li Y, Lin K Int J Equity Health. 2025; 24(1):1.

PMID: 39748411 PMC: 11697884. DOI: 10.1186/s12939-024-02368-0.


Stigma and associated sex disparities among patients with tuberculosis in Uganda: a cross-sectional study.

Sekandi J, Quach T, Olum R, Nakkonde D, Farist L, Obiekwe R Ther Adv Infect Dis. 2024; 11:20499361241305517.

PMID: 39678997 PMC: 11645763. DOI: 10.1177/20499361241305517.


Treatment preferences among people at risk of developing tuberculosis: A discrete choice experiment.

Kamchedzera W, Quaife M, Msukwa-Panje W, Burke R, Macpherson L, Kumwenda M PLOS Glob Public Health. 2024; 4(7):e0002804.

PMID: 39028696 PMC: 11259259. DOI: 10.1371/journal.pgph.0002804.


Determinant of catastrophic costs associated with treatment for rifampicin-resistant TB in households in the Republic of Moldova.

Ciobanu A, Plesca V, Doltu S, Manea M, Domente L, Dadu A IJTLD Open. 2024; 1(6):266-273.

PMID: 39021450 PMC: 11249656. DOI: 10.5588/ijtldopen.23.0608.


References
1.
Nhung N, Hoa N, Anh N, Anh L, Siroka A, Lonnroth K . Measuring catastrophic costs due to tuberculosis in Viet Nam. Int J Tuberc Lung Dis. 2018; 22(9):983-990. DOI: 10.5588/ijtld.17.0859. View

2.
Okello D, Floyd K, Adatu F, Odeke R, Gargioni G . Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S72-9. View

3.
Fuady A, Houweling T, Mansyur M, Richardus J . Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage. Infect Dis Poverty. 2018; 7(1):3. PMC: 5765643. DOI: 10.1186/s40249-017-0382-3. View

4.
Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K . Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014; 43(6):1763-75. PMC: 4040181. DOI: 10.1183/09031936.00193413. View

5.
Timire C, Ngwenya M, Chirenda J, Metcalfe J, Kranzer K, Pedrazzoli D . Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey. Trop Med Int Health. 2021; 26(10):1248-1255. PMC: 8519355. DOI: 10.1111/tmi.13647. View